Position

Head of Microbiology & Infectious Diseases
Microbiology & Infectious Diseases

Publications

  • Tucker, E. and Gordon, D. (2012). Miscellaneous antibacterial drugs. In Aronson, Jeffrey, ed. Side Effects of Drugs Annual 34. Amsterdam, Netherlands: Elsevier, pp. 399-425.
    [10.1016/B978-0-444-59499-0.00026-X] [Scopus]
  • Tucker, E. and Gordon, D. (2012). Miscellaneous antibacterial drugs. In Side Effects of Drugs Annual 34. U.K.: Elsevier, pp. 399-425.
    [10.1016/B978-0-444-59499-0.00026-X]
  • Gordon, D.L. (2010). Amoxicillin-Clavulanic Acid (Co-Amoxiclav) In M. Lindsay Grayson, ed. Kucers' The Use of Antibiotics. 6th ed. United Kingdom: Hodder, pp. 187-203.
  • Gordon, D.L. (2010). Meningitis and Encephalitis. In Margaret Schuller, Theo P. Sloots, Gregory S. James, Catriona L. Halliday, Ivan W.J. Carter, ed. PCR for Clinical Microbiology. Australia: Springer, pp. 63-66.
    [10.1007/978-90-481-9039-3_4] [Scopus]
  • Wesselingh, S. and Gordon, D. (1993). Foetal infections. Clinical Problems and Laboratory Diagnosis. In JP Neilson & SE Chambers, ed. Obstetric Ultrasound 1. New York: Oxford University Press, pp. 117-132.
    [Web Link]
  • Gordon, D. (1991). Staphylococcal infections. In NA, ed. MIMS Disease Index. UK: IMS Publishing.
  • Gordon, D. (1989). Complement and natural immunity. In David Selwyn Nelson, ed. Natural Immunity. Sydney: Academic Press, pp. 218-240.
    [Web Link]
  • Gordon, D. (1988). Mode of action of antimicrobials. In Ruth Dircks, ed. Disease and Society. Australia: Australian Academy of Science, pp. 999-999.
    [Web Link]
  • Phillips, C., Wells, N., Martinello, M., Smith, S. and Gordon, D. (2014). Effect of methodology on vancomycin MIC for MRSA isolates D-871. In Book of Abstracts. American Society for Microbiology. Interscience Congress on Antimicrobial Agents and Chemotherapy (ICAAC) Washington D.C. Sep 2014.
    [Web Link]
  • Phillips, C.J., Martinello, M., Doogue, M. and Gordon, D. (2013). Does the addition of a face-to-face educational session to an online continuing medical education module improve vancomycin prescribing and monitoring knowledge? In Federation of Infections Societies UK Action on Infection 2013. British Society for Antimicrobial Chemotherapy. Action on Infection. Birmingham, UK. Nov 2013.
  • Phillips, C.J., Martinello, M., Doogue, M. and Gordon, D. (2013). A structured education program improves intern confidence in prescribing and monitoring vancomycin. In 18th National Prevocational Medical Education Forum Program Book. 18th National Prevocational Medical Education Forum. Adelaide, SA. Nov 2013.
  • Phillips, C.J., Doan, H.T., Quinn, S.J., Kirkpatrick, C.M., Gordon, D.L. and Doogue, M.P. (2012). Improving vancomycin prescribing and monitoring with staff education and support. In Program and Book of Abstracts, Antimicrobials 2012, The Australian Society for Antimicrobials. South Perth, WA: The Australian Society for Antimicrobials. Antimicrobials 2012. Brisbane. Feb 2012, pp. 52-52.
  • Phillips, C.J., Spark, J.I., Doan, H.T., Quinn, S.J., Kirkpatrick, C.M., Gordon, D.L., et al. (2011). Improving vancomycin prescribing and monitoring: an intervention using staff education and support in a vascular unit. In The Annual Scientific Congress of The Australian and New Zealand Society for Vascular Surgery. East Melbourne: Royal Australasian College of Surgeons. Vascular 211. Brisbane. Nov 2011.
  • Gordon, D.L., Sadlon, T., Tan, S.D., Hidayatullah, T. and Wan, E.C. (2010). Detection of antibody against H1N1 2009 Influenza using recombinant GPI-anchored hemagglutinin. In Proceedings of Annual Scientific Meeting Australian Society for Microbiology. Annual Scientific Meeting Australian Society for Microbiology. Sydney. Jul 2010, pp. 75-75.
  • Gordon, D.L., Petrovsky, N., Sadlon, T., Tan, S.D., Honda-Okubo, Y., Phillips, P., et al. (2010). Pattern of serological responses following novel H1N1 2009 Influenza A infection in adults. In Proceedings of Annual Scientific Meeting Australian Society for Microbiology. AustraliaAnnual Scientific Meeting Australian Society for Microbiology. Sydney. Jul 2010, pp. 104-104.
  • Gordon, D.L., Honda-Okubo, Y., Sajkov, D., Woodman, R.J., Petrovsky, N., Heinzel, S., et al. (2010). Immunogenicity and safety of a unique Influenza A (2009 H1N1) vaccine combining recombinant hemagglutinin with a novel polysaccharide adjuvant. In Proceedings of Annual Scientific Meeting Australian Society for Microbiology. The Australian Society for Microbiology Annual Scientific Meeting. Sydney. Jul 2010, pp. 56-56.
  • Gordon, D.L., Sadlon, T., Weightman, W. and Sengupta, S. (2010). Merkel cell polyomavirus in a Merkel cell carcinoma from a psoriatic patient treated with Efalizumab. In Proceedings of Annual Scientific Meeting Australian Society for Microbiology. The Australian Society for Microbiology Annual Scientific Meeting. Sydney. Jul 2010, pp. 118-118.
  • Gordon, D.L., Sadlon, T., Woolley, M., Hakendorf, P.H., Milios, K., Riddle, C., et al. (2010). Performance characteristics of PCR for detection of novel H1N1 2009 Influenza virus in respiratory specimens. In Proceedings of Australian Society for Microbiology Annual Scientific Meeting. The Australian Society for Microbiology Annual Scientific Meeting. Sydney. Jul 2010, pp. 104-104.
  • Worthley, D., Mullighan, C.G., Dean, M.M., Gordon, D.L., Phillips, P., Heatley, S., et al. (2007). Mannose-Binding Lectin Deficiency Does Not Predispose to Helicobacter pylori Infection. In Gastroenterology. W.B. Saunders. Digestive Disease Week 2007. Washington, DC. May 2007, pp. A 709-A 709.
  • Gordon, D.L., Johnson, B., Bouchillon, S., Pruul, H. and Dowzicky, M. (2006). Tigecycline evaluation surveillance trial (T.E.S.T.) program - in-vitro antibacterial activity of tigecycline at Flinders Medical Centre, South Australia. In Proceedings of the Australian Society for Antimicrobials Annual Scientific Meeting 2006. Antimicrobials 2006: Australian Society for Antimicrobials Annual Scientific Meeting. Sydney, NSW. Feb 2006.
  • Gordon, D.L., Wilson, D., Woolley, M., Wetherall, B.L. and Tabner, A. (2006). MRSA Infection in a Microbiologist. In Australian Society for Microbiology 2006 ASM Program and Abstract Book. West Leederville, WA: Cambridge Publishing. Ride the Wave: Microbiology with Innovation - The 2006 ASM of the Australian Society for Microbiology. Gold Coast, QLD. Jul 2006, pp. 148-148.
  • Hallsworth, P.G., Wilson, D. and Gordon, D.L. (2006). Hepatitis C Testing: The Need for a New Algorithm? In Australian Society for Microbiology 2006 ASM Program and Abstract Book. West Leederville, WA: Cambridge Publishing. Ride the Wave: Microbiology with Innovation - The 2006 ASM of the Australian Society for Microbiology. Gold Coast, QLD. Jul 2006, pp. 139-139.
  • Wetherall, B.L., Brannigan, K., Woolley, M. and Gordon, D.L. (2006). Desulfovibrio fairfieldensis Bacteraemia. In Australian Society for Microbiology 2006 ASM Program and Abstract Book. West Leederville, WA: Cambridge Publishing. Ride the Wave: Microbiology with Innovation - The 2006 ASM of the Australian Society for Microbiology. Gold Coast, QLD. Jul 2006, pp. 101-101.
  • Woolley, M., Gordon, D.L. and Wetherall, B.L. (2006). Genotyping of Bartonella quintana. In Australian Society for Microbiology 2006 ASM Program and Abstract Book. West Leederville, WA: Cambridge Publishing. Ride the Wave: Microbiology with Innovation - The 2006 ASM of the Australian Society for Microbiology. Gold Coast, QLD. Jul 2006, pp. 157-157.
  • Gordon, D.L. (2002). Pathogenesis of Group A Streptococcal disease, pp. 1.
  • Mahdi, L.K., Higgins, M., day, C., Tiralongo, J., Hartley-Tassell, L.E., Jennings, M.P., et al. (2017). The pneumococcal alpha-glycerophosphate oxidase enhances nasopharyngeal colonization through binding to host glycoconjugates. EBioMedicine, 18 pp. 236-243.
  • Ashokan, A., Christensen, A. and Gordon, D.L. (2017). A Rash Diagnosis. MJA Medical Journal of Australia, 206 pp. 483-484.
  • Phillips, C., McKinnon, R.A., Woodman, R.J. and Gordon, D.L. (2017). Junior doctors’ preparedness to prescribe, monitor and treat patients with the antibiotic vancomycin in an Australian teaching hospital. Journal of Educational Evaluation for Health Professions, 14
  • Kennedy, B., Larcombe, R., Chaptini, C. and Gordon, D. (2015). Interaction between Voriconazole and Flucloxacillin during treatment of disseminated Scedosporium apiospermum infection. Journal of Antimicrobial Chemotherapy,
  • Thammawat, S., Sadlon, T.A., Adamson, P. and Gordon, D.L. (2015). Effect of sialidase fusion protein (DAS 181) on human metapneumovirus infection of Hep-2 cells. Antiviral Chemistry and Chemotherapy, 24 pp. 161-165.
  • Cugati, S., Gilhotra, J., Lake, S. and Gordon, D. (2014). Ocular involvement following Bacillus Calmette-Guerin immunotherapy for bladder carcinoma. Clinical and Experimental Ophthalmology, 42(5) pp. 494-495.
    [10.1111/ceo.12252] [Scopus]
  • Adamson, P., Thammawat, S., Muchondo, G., Sadlon, T., Williams, J. and Gordon, D. (2013). hMPV lineage nomenclature and heparin binding. Viruses, 5(10) pp. 2546-2547.
    [10.3390/v5102546] [Scopus]
  • Phillips, C., Doan, H., Quinn, S., Kirkpatrick, C., Gordon, D. and Doogue, M. (2013). An educational intervention to improve vancomycin prescribing and monitoring. International Journal of Antimicrobial Agents, 41(4) pp. 393-394.
    [Scopus] [Web Link]
  • Anagnostou, N., Siddins, M. and Gordon, D. (2012). Encrusted Cystitis and Pyelitis. Internal Medicine Journal, 42(5) pp. 596-597.
    [10.1111/j.1445-5994.2012.02773.x] [Scopus]
  • Reed, J.H., Thurgood, L.A., Gordon, D.L. and Gordon, T.P. (2010). Differential activation of complement by apoptotic cells opsonised with anti-Ro60 and anti-La autoantibodies. Scandinavian Journal of Immunology, 72(3) pp. 260-261.
    [10.1111/j.1365-3083.2010.02420.x] [Scopus]
  • Gordon, D.L. and Kelley, P. (2008). Cat Got Your Tongue? Clinical Infectious Diseases, 46(1) pp. 146-146.
    [10.1086/523723] [Scopus]
  • Caram, L.B., Linefsky, J.P., Read, K.M., Murdoch, D.R., Lalani, T., Woods, C.W., et al. (2008). Leptotrichia endocarditis: Report of two cases from the International Collaboration on Endocarditis (ICE) database and review of previous cases. European Journal of Clinical Microbiology and Infectious Diseases, 27(2) pp. 139-143.
    [10.1007/s10096-007-0406-1] [Scopus]
  • Stryjewski, M.E., Graham, D., Wilson, S.E., O'Riordan, W., Young, D., Letnek, A., et al. (2008). Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin-Structure Infections Caused by Gram-Positive Organisms. Clinical Infectious Diseases, 46 pp. 1683-1693.
    [10.1086/587896] [Scopus]
  • Boyd, M.A., Menon, P., Graves, S.E. and Gordon, D.L. (2007). A febrile illness with generalized papular rash involving the palms and soles. Clinical Infectious Diseases, 44 pp. 704-704.
    [10.1086/511637] [Scopus]
  • Dickerman, S., Abrutyn, E., Barsic, B., Bouza, E., Cecchi, E., Moreno, A., et al. (2007). The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: An analysis from the ICE Prospective Cohort Study (ICE-PCS) American Heart Journal, 154(6) pp. 1086-1094.
    [10.1016/j.ahj.2007.07.023] [Scopus]
  • Morpeth, S., Murdoch, D., Cabell, C.H., Karchmer, A.W., Pappas, P.A., Levine, D.P., et al. (2007). Non-HACEK Gram-Negative Bacillus Endocarditis. Annals of Internal Medicine, 147(12) pp. 829-835.
    [Scopus]
  • Swaminathan, S., Kelley, P., Ahern, M.J. and Gordon, D.L. (2007). Acute cytomegalovirus infection presenting with severe vulvar swelling. International Journal of Gynecology and Obstetrics, 99(2) pp. 133-134.
    [10.1016/j.ijgo.2007.04.035] [Scopus] [Web Link]
  • Wang, A., Athan, E., Pappas, P.A., Fowler, V.G., Olaison, L., Pare, C., et al. (2007). Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA-Journal of The American Medical Association, 297(12) pp. 1354-1361.
    [10.1001/jama.297.12.1354] [Scopus]
  • Worthley, D., Bardy, P., Gordon, D.L. and Mullighan, C.G. (2007). Mannose-binding lectin and gastric cancer. International Journal of Cancer, 120(12) pp. 2751-2752.
    [10.1002/ijc.22662] [Scopus]
  • Chen, S., Slavin, M., Nguyen, Q., Deborah, M., Playford, G., Ellis, D., et al. (2006). Active Surveillance for Candidemia, Australia. Emerging Infectious Diseases, 12(10) pp. 1508-1516.
    [Scopus]
  • Gordon, D.L. (2006). D Morikis, JD Lambris (eds), 'Structural Biology of the Complement Systems' (book review) Immunology and Cell Biology, 84 pp. 486-486.
    [10.1111/j.1440-1711.2006.01470.x]
  • Maiwald, M.G., Farmer, C.J.M., Lance, D.G., Nieuwenhuijs, V., Heath, C.H., Watson, D.I., et al. (2006). Surgical antisepsis and the risk of operating theatre fires. ANZ Journal of Surgery, 76(5) pp. 422-423.
    [10.1111/j.1445-2197.2006.03736.x] [Scopus]
  • Dyer, J.R., Einsiedel, L.J., Ferguson, P.E., Lee, A.S., Unsworth, N.B., Graves, S.E., et al. (2005). A new focus of Rickettsia honei spotted fever in South Australia. Medical Journal of Australia, 182(5) pp. 231-234.
    [Scopus] [Web Link]
  • Einsiedel, L., Kat, E., Ravindran, J., Slavotinek, J.P. and Gordon, D.L. (2003). MR findings in Murray Valley encephalitis. American Journal of Neuroradiology, 24(7) pp. 1379-1382.
    [Scopus] [Web Link]
  • Gordon, D.L. (2003). Antibiotic prophylaxis. How, when and why. Critical Care and Resuscitation, 5(3) pp. 169-170.
    [Web Link]
  • Duthy, T.G., Mcrae, D., Griggs, K.M., Murphy, B.F. and Gordon, D.L. (2002). Functional characterization of human factor H-related protein 5 (FHR-5) reveals heparin binding and novel cofactor activity. International Immunopharmacology, 2(9) pp. 1223-1223.
  • Jokiranta, T.S., Giannakis, E., Ormsby, R.J., Lindahl, G. and Gordon, D.L. (2002). Structural analysis of the interaction between M5 protein and factor H domain 7 and identification of a distinct M protein binding site on domains 8-15 [abstract] International Immunopharmacology, 2(9) pp. 1343-1344.
  • Ormsby, R.J., Hellwage, J., Male, D.A., Zipfel, P.F. and Gordon, D.L. (2002). Transcriptional regulation of the factor H-related genes [abstract] International Immunopharmacology, 2(9) pp. 1264-1265.
  • Jokiranta, T.S., Ormsby, R.J., Gordon, D.L., Zipfel, P.F., Meri, S. and Hellwage, J. (2002). Identification of the domain and amino acids needed for Factor H dimerization [abstract] International Immunopharmacology, 2(9) pp. 1276-1276.
  • Gordon, D.L. (2001). Rare and emerging infections. Critical Care and Resuscitation, 3(4) pp. 221-229.
    [Web Link]
  • Read, K., Currie, B., McDonald, P. and Gordon, D. (2001). Reactivation of latent melioidosis in association with staphylococcal endocarditis. Internal Medicine Journal, 31(2) pp. 130-131.
    [10.1111/j.1444-0903.2001.00022.x] [Web Link]
  • Read, K.M., Currie, B.J., McDonald, P.J. and Gordon, D.L. (2001). Reactivation of latent meliodosis in association with staphylococcal endocarditis. Internal Medicine Journal, 31 pp. 130-131.
  • Read, K.M., Kennedy-Andrews, S. and Gordon, D.L. (2001). Amoebic liver abscess in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology, 41(2) pp. 236-237.
    [Web Link]
  • Gordon, D. (1999). Antibiotic prophylaxis and vasectomy. Modern Medicine, 42 pp. 17.
  • Lee, Y.C., Gordon, D. and Gordon, L. (1999). Epoxy resin allergy from microscopy immersion oil. Australasian Journal of Dermatology, 40(4) pp. 228-229.
    [10.1046/j.1440-0960.1999.00370.x] [Scopus] [Web Link]
  • Flint, J., Ryan, P. and Gordon, D. (1998). Prevalence of MRSA in South Australian nursing homes. Medical Journal of Australia, 169(10) pp. 559-560.
    [Web Link]
  • Papanaoum, K., Marshmann, G., Gordon, L., Lumb, R. and Gordon, D. (1998). Concurrent infection due to Shewanella putrefaciens and Mycobacterium marinum acquired at the beach. Australasian Journal of Dermatology, 39(2) pp. 92-95.
    [Web Link]
  • Heath, C., Lendrum, J., Wetherall, B., Wesselingh, S. and Gordon, D. (1997). Phaeoacremonium parasiticum Infective endocarditis following liver transplantation. Clinical Infectious Diseases, 25(5) pp. 1251-1252.
    [Web Link] [Web Link]
  • Blackmore, T. and Gordon, D. (1996). The Delta Trial. Lancet, 348(9036) pp. 1238-1239.
    [10.1016/S0140-6736(05)65508-0]
  • Carron, J., Bates, R., Smith, A., Tetoz, T., Arellano, A., Gordon, D., et al. (1996). Factor H co-purifies with thrombospondin isolated from platelet secretate. Biochimica Et Biophysica Acta (BBA) - Biomembranes, 1289(3) pp. 305-311.
    [10.1016/0304-4165(95)00095-X] [Scopus]
  • Blackmore, T., Wesselingh, S. and Gordon, D. (1995). Flucloxacillin hepatitis: an Australian epidemic. Australian and New Zealand Journal of Medicine, 25(5) pp. 537-537.
    [10.1111/j.1445-5994.1995.tb01520.x] [Web Link]
  • McBride, W., Hill, D. and Gordon, D. (1995). Chest wall actinomycosis in association with the use of an intra-uterine device. ANZ Journal of Surgery, 65(2) pp. 141-143.
    [Web Link]
  • Barrington, D. and Gordon, D. (1994). Infection Control for general practice. II. Guidelines for infection control in general practice rooms. Australian Family Physician, 23 pp. 440-441.
  • Blackmore, T., Slavotinek, J. and Gordon, D. (1994). Cystic pulmonary lesions in Pneumocystis carinii infection. Australasian Radiology, 38(2) pp. 138-140.
    [Web Link]
  • Blackmore, T., Morley, H. and Gordon, D. (1993). Streptococcus mitis-induced bacteremia and meningitis after spinal anesthesia. Anesthesiology, 78(3) pp. 592-594.
    [Web Link]
  • Cooper, C., Gordon, D., Reid, C. and Philpott, C. (1992). Cutaneous cryptococcosi: a recurrence following a course of oral fluconazole. Australasian Journal of Dermatology, 33(2) pp. 93-96.
    [10.1111/j.1440-0960.1992.tb00088.x] [Web Link]
  • Gordon, D. and Maddern, J. (1992). Treatment of candida epididymo-orchitis with oral fluconazole. Medical Journal of Australia, 156(10) pp. 744-744.
    [Web Link] [Web Link]
  • Nankivell, B., Pacey, D. and Gordon, D. (1991). Peritoneal eosinophilia associated with Paecilomyces variotii infection in continuous ambulatory peritoneal dialysis. American Journal of Kidney Diseases, 18(5) pp. 603-605.
  • Gordon, D. (1989). Meningococcal disease and complement. Medical Journal of Australia, 150 pp. 286-286.
  • Gordon, D. (1989). The complete guide to immunisation, Elderly, and Immunocompromised. Current Therapeutics, pp. 81-87.
  • Mcdonald, H. and Gordon, D. (1988). Capnocytophaga species: a cause of amniotic fluid infection and preterm labour. Pathology, 20(1) pp. 74-76.
    [10.3109/00313028809085203] [Web Link]
  • Hostetter, M. and Gordon, D. (1987). The biochemistry of C3 and related thiolester proteins in infection and inflammation. Reviews of Infectious Diseases, 9(1) pp. 97-109.
    [Web Link]
  • Gordon, L. and Gordon, D. (1987). Cryptococcal infection simulating varicella. Australasian Journal of Dermatology, 28(1) pp. 24-26.
    [10.1111/j.1440-0960.1987.tb00324.x] [Web Link]
  • Gordon, D., Philpott, C. and McGuire, C. (1983). Plesiomonas shigelloides septic arthritis complicating rheumatoid arthritis. Australian and New Zealand Journal of Medicine, 13(3) pp. 275-276.
    [10.1111/j.1445-5994.1983.tb04657.x] [Web Link]
  • Gordon, D. (1987). Interaction of complement component C3 with bacteria and phagocytic cells.
  • Phillips, C., McKinnon, R.A., Woodman, R.J. and Gordon, D.L. (2017). Sustained improvement in vancomycin dosing and monitoring post implementation of guidelines: results of a three-year follow-up after a multifaceted intervention. JOURNAL OF INFECTION AND CHEMOTHERAPY,
  • Phillips, C., McKinnon, R.A., Woodman, R.J. and Gordon, D.L. (2017). Junior doctors’ preparedness to prescribe, monitor and treat patients with the antibiotic vancomycin in an Australian teaching hospital. Journal of Educational Evaluation for Health Professionals, 14(13)
    [10.3352/jeehp.2017.14.13]
  • Adamson, P., Al Kindi, M., Wang, J.J., Colella, A., Chataway, T.K., Petrovsky, N., et al. (2017). Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures. Vaccine, 35(42) pp. 5576-5580.
    [10.1016/j.vaccine.2017.08.053] [Scopus]
  • Honda-Okubo, Y., Rajapaksha, H., Sajkov, D., Gordon, D.L., Cox, M.M. and Petrovsky, N. (2017). Panblok-H1+Advax H1N1/2009pdm vaccine: insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine. Human Vaccines & Immunotherapeutics,
    [10.1080/21645515.2017.1279765]
  • Thompson, V.C., Adamson, P., Dilag, J., Uswatte Liyanage, D.B.U., Srikantharajah, K., Blok, A.J., et al. (2016). Biocompatible anti-microbial coatings for urinary catheters. RSC Advances, 6 pp. 53303-53309.
    [10.1039/c6ra07678e] [Scopus]
  • Taylor, S.L., Woodman, R.J., Chen, A.C., Burr, L.D., Gordon, D.L., McGuckin, M.A., et al. (2016). FUT2 genotype influences lung function, exacerbation frequency and airway microbiota in non-CF bronchiectasis. Thorax,
    [10.1136/thoraxjnl-2016-208775]
  • Smith, S., Adamson, P., Sadlon, T.A. and Gordon, D.L. (2016). Prevalence of macrolide-resistant Mycoplasma pneumoniae in South Australia. Pathology, 48(6) pp. 639-642.
    [10.1016/j.pathol.2016.06.004]
  • Phillips, C., Wells, N.A., Martinello, M., Smith, S., Woodman, R.J. and Gordon, D.L. (2016). Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range. Infection and Drug Resistance, 9 pp. 87-92.
    [10.2147/IDR.S107961] [Scopus] [Web Link]
  • Gordon, D.L., Sajkov, D., Honda-Okubo, Y., Wilks, S.H., Aban, M., Barr, I.G., et al. (2016). Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with AdvaxTM Delta Inulin Adjuvant. Vaccine, 34(33) pp. 3780-3786.
    [10.1016/j.vaccine.2016.05.071]
  • Hewagama, S., Spelman, T., Woolley, M., McLeod, J., Gordon, D.L. and Einsiedel, L.J. (2016). The Epidemiology of Staphylococcus aureus and Panton-Valentine Leucocidin (pvl) in Central Australia, 2006-2010. BMC Infectious Diseases, 16 pp. 382-387.
    [10.1186/s12879-016-1698-5]
  • Phadnis, J., Gordon, D.L., Krishnan, J. and Bain, G.I. (2016). Frequent isolation of Propionibacterium acnes from the shoulder dermis despite skin preparation and prophylactic antibiotics. Journal of Shoulder and Elbow Surgery, 25(2) pp. 304-310.
    [Scopus]
  • Wisdom, A., Eaton, V., Gordon, D., Daniel, S., Woodman, R. and Phillips, C. (2015). INITIAT-E.D.: Impact of timing of INITIation of antibiotic therapy on mortality of patients presenting to an Emergency Department with sepsis. Emergency Medicine Australasia, 27 pp. 196-201.
    [10.1111/1742-6723.12394] [Scopus]
  • Phillips, C. and Gordon, D.L. (2015). Pharmacist-led implementation of a vancomycin guideline across medical and surgical units: impact on clinical behaviour and therapeutic drug monitoring outcomes. Integrated Pharmacy Research and Practice, 2015(4) pp. 145-152.
    [10.2147/IPRP.S92850]
  • Delahaye, F., Chu, V., Altclas, J., Barsic, B., Delahaye, A., Freiberger, T., et al. (2015). One-year outcome following biological or mechanical valve replacement for infective endocarditis. International Journal of Cardiology, 178 pp. 117-123.
    [Scopus]
  • Grayson, M.L., Macesic, N., Huang, G.K., Bond, K., Fletcher, J., Gilbert, G., et al. (2015). Use of an innovative personality-mindset profiling tool to guide culture-change strategies among different healthcare worker groups. PLoS One, 10(10) pp. Art: e0140509.
    [10.1371/journal.pone.0140509]
  • Hooper, T.D., Hibbert, P., Hannaford, N., Jackson, N., Hindmarsh, D.M., Gordon, D.L., et al. (2015). Surgical site infection-a population-based study in Australian adults measuring the compliance with and correct timing of appropriate antibiotic prophylaxis. Anaesthesia and Intensive Care, 43(4) pp. 461-467.
    [Scopus]
  • Gordon, D., Kelley, P., Heinzel, S., Cooper, P. and Petrovsky, N. (2014). Immunogenicity and safety of Advax TM, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface anitgen: a randomized controlled Phase 1 study. Vaccine, 32 pp. 6469-6477.
    [Scopus]
  • Ingram, P.R., Cheng, A., Murray, R.J., Blyth, C.C., Walls, T., Fisher, D.A., et al. (2014). What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore. CLINICAL MICROBIOLOGY AND INFECTION, 20(10) pp. O737-O744.
    [10.1111/1469-0691.12581] [Scopus]
  • Lalani, T., Chu, V., Park, L., Cecchi, E., Corey, G., Durante-Mangoni, E., et al. (2013). In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA-Journal of The American Medical Association, 173(16) pp. 1495-1504.
    [10.1001/jamainternmed.2013.8203] [Scopus]
  • Hawke, K.G., Waddell, R., Gordon, D., Ratcliff, R., Ward, P. and Kaldor, J. (2013). HIV Non-B Subtype Distribution: Emerging Trends and Risk Factors for Imported and Local Infections Newly Diagnosed in South Australia. Aids Research and Human Retroviruses, 29(2) pp. 311-317.
    [10.1089/aid.2012.0082] [Scopus]
  • Alagna, L., Park, L.P., Nicholson, B., Keiger, A., Strahilevitz, J., Morris, A., et al. (2013). Repeat endocarditis: Analysis of risk factors based on the International Collaboration on Endocarditis - Prospective Cohort Study. CLINICAL MICROBIOLOGY AND INFECTION, 20(6) pp. 566-575.
    [10.1111/1469-0691.12395] [Scopus]
  • Gordon, D., Sajkov, D., Woodman, R., Honda-Okubo, Y., Cox, M.M.J., Heinzel, S., et al. (2012). Randomized clinical trial of immunogenicity and safety of recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant. Vaccine, 30(36) pp. 5407-5416.
    [10.1016/j.vaccine.2012.06.009] [Scopus]
  • Muller, K., Rodgers, A., Wundke, R., Waddell, V., Altus, R., Gordon, D., et al. (2012). Single centre experience with pegylated interferon and ribavirin for hepatitis C: looking back before moving foward. Internal Medicine Journal, 42(7) pp. 765-772.
    [10.1111/j.1445-5994.2012.02798.x] [Scopus]
  • Papanicolas, L., Hakendorf, P. and Gordon, D. (2012). Concomitant Septic Arthritis in Crystal Monoarthritis. Journal of Rheumatology, 39(1) pp. 157-160.
    [10.3899/jrheum.110368] [Scopus]
  • Adamson, P., Thammawat, S., Muchondo, G., Sadlon, T. and Gordon, D. (2012). Diversity in Glycosaminoglycan Binding Amongst hMPV G Protein Lineages. Viruses, 4(12) pp. 3785-3803.
    [10.3390/v4123785] [Scopus]
  • Athan, E., Chu, V., Tattevin, P., Selton-Suty, C., Jones, P., Naber, C., et al. (2012). Clinical Characteristics and Outcome of Infective Endocarditis Involving Implantable Cardiac Devices. JAMA-Journal of The American Medical Association, 307(16) pp. 1727-1735.
    [10.1001/jama.2012.497] [Scopus]
  • Tan, S., Gordon, D., Honda-Okubo, Y., Petrovsky, N., Phillips, P., Huddleston, S., et al. (2011). Serological responses following influenza A H1N1 2009 infection in adults. Journal of Infection, 62(5) pp. 388-393.
    [10.1016/j.jinf.2011.03.002] [Scopus]
  • Kanafani, Z.F., Kanj, S.S., Cabell, C.H., Cecchi, E., de Oliveira Ramos, A., Lejko-Zupanc, T., et al. (2010). Revisiting the effect of referral bias on the clinical spectrum of infective endocarditis in adults . European Journal of Clinical Microbiology and Infectious Diseases, 29(10) pp. 1203-1210.
    [10.1007/s10096-010-0983-2] [Scopus]
  • Anstey, J.R., Fazio, T.N., Gordon, D.L., Hogg, G., Jenney, A.W., Maiwald, M.G., et al. (2010). Community-acquried Klebsiella pneumoniae liver abscesses - an emerging disease in Australia. Medical Journal of Australia, 193(9) pp. 543-545.
    [Scopus]
  • Turnidge, J.D., Kotsanas, D., Munckhof, W., Roberts, S., Bennett, C.M., Nimmo, G.R., et al. (2009). Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. MJA Medical Journal of Australia, 191(7) pp. 368-373.
    [Scopus]
  • Martin, A., Bloch, M., Amin, J., Baker, D., Cooper, D.A., Emery, S., et al. (2009). Simplification of antiretroviral therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: a randomized, 96-week trial. Clinical Infectious Diseases, 49(10) pp. 1591-1601.
    [10.1086/644769] [Scopus]
  • Benito, N., Miro, J.M., de Lazzari, E., Cabell, C.H., del Rio, A., Altclas, J.D., et al. (2009). Health care-associated native valve endocarditis : importance of non-nosocomial acquisition. Annals of Internal Medicine, 150(9) pp. 586-594.
    [Scopus]
  • Okemefuna, A.I., Li, K., Nan, R., Ormsby, R.J., Sadlon, T., Gordon, D.L., et al. (2009). Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation. Journal of Molecular Biology, 391(1) pp. 119-135.
    [10.1016/j.jmb.2009.06.013] [Scopus]
  • Ogunniyi, A.D., Grabowicz, M., Mahdi, L.K., Cook, J., Gordon, D.L., Sadlon, T., et al. (2009). Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. FASEB Journal, 23(3) pp. 731-738.
    [10.1096/fj.08-119537] [Scopus]
  • Eisen, D.P., Corey, G.R., McBryde, E.S., Fowler, V.G., Miro, J.M., Cabell, C.H., et al. (2009). Reduced valve replacement surgery and complication rate in staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid. Journal of Infection, 58(5) pp. 332-338.
    [10.1016/j.jinf.2009.03.006] [Scopus]
  • Unicomb, L., O'Reilly, L., Kirk, M., Stafford, R., Smith, H., Becker, N., et al. (2008). Risk factors for infection with Campylobacter jejuni flaA genotypes. Epidemiology and Infection, 136(11) pp. 1480-1491.
    [10.1017/S0950268807000246] [Scopus]
  • Thammawat, S., Sadlon, T., Hallsworth, P.G. and Gordon, D.L. (2008). Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection. Journal of Virology, 82(23) pp. 11767-11774.
    [10.1128/JVI.01208-08] [Scopus]
  • Simmon, K.E., Hall, L., Woods, C.W., Marco, F., Miro, J.M., Cabell, C.H., et al. (2008). Phylogenetic analysis of viridans group streptococci causing endocarditis. Journal of Clinical Microbiology, 46(9) pp. 3087-3090.
    [10.1128/JCM.00920-08] [Scopus]
  • Petti, C.A., Simmon, K.E., Miro, J.M., Hoen, B., Marco, F., Chu, V.H., et al. (2008). Genotypic diversity of coagulase-negative staphylococci causing endocarditis: a global perspective. Journal of Clinical Microbiology, 46(5) pp. 1780-1784.
    [10.1128/JCM.02405-07] [Scopus]
  • Ormsby, R.J., Ranganathan, S., Tong, J.C., Griggs, K.M., Dimasi, D.P., Hewitt, A.W., et al. (2008). Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration. Investigative Ophthalmology and Visual Science, 49(5) pp. 1763-1770.
    [10.1167/iovs.07-1297] [Scopus]
  • Okemefuna, A.I., Gilbert, H.E., Griggs, K.M., Ormsby, R.J., Gordon, D.L. and Perkins, S.J. (2008). The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties. Journal of Molecular Biology, 375(1) pp. 80-101.
    [10.1016/j.jmb.2007.09.026] [Scopus]
  • Giacomin, P.R., Gordon, D.L., Daha, M.R., Sanderson, S.D., Taylor, S.M., Dent, L.A., et al. (2008). The role of complement in innate, adaptive and eosinophil-dependent immunity to the nematode Nippostrongylus brasiliensis. Molecular Immunology, 45(2) pp. 446-455.
    [10.1016/j.molimm.2007.05.029] [Scopus]
  • Giacomin, P.R., Cava, M., Tumes, D.J., Gauld, A.D., Iddawela, D.R., McColl, S.R., et al. (2008). Toxocara canis larval excretory/secretory proteins impair eosinophil-dependent resistance of mice to Nippostrongylus brasiliensis. Parasite Immunology, 30(8) pp. 435-445.
    [10.1111/j.1365-3024.2008.01040.x] [Scopus]
  • Chu, V.H., Woods, C.W., Miro, J.M., Cabell, C.H., Pappas, P.A., Federspiel, J., et al. (2008). Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clinical Infectious Diseases, 46(2) pp. 232-242.
    [10.1086/524666] [Scopus]
  • Djordjevic, S., Unicomb, L., Adamson, P., Mickan, L., Rios, R., Cheung, K., et al. (2007). Clonal complexes of Campylobacter jejuni identified by multilocus sequence typing are reliably predicted by restriction fragment length polymorphism analyses of the flaA gene. Journal of Clinical Microbiology, 45(1) pp. 102-108.
    [10.1128/JCM.01012-06] [Scopus]
  • Lalani, T., Person, A., Hedayati, S., Moore, L., Murdoch, D., Hoen, B., et al. (2007). Propionibacterium endocarditis: A Case Series from the International Collaboration on Endocarditis Merged Database and Prospective Cohort Study. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 39(10) pp. 840-848.
    [10.1080/00365540701367793] [Scopus]
  • Mickan, L., Doyle, R., Valcanis, M., Dingle, K., Unicomb, L., Lanser, J., et al. (2007). Multilocus sequence typing of Campylobacter jejuni isolates from New South Wales, Australia. Journal of Applied Microbiology, 102(1) pp. 144-152.
    [10.1111/j.1365-2672.2006.03049.x] [Scopus]
  • Woolley, M., Wetherall, B.L. and Gordon, D.L. (2007). Analysis of the first Australian strains of Bartonella quintana reveals unique genotypes. Journal of Clinical Microbiology, 45(6) pp. 2040-2043.
    [10.1128/JCM.00175-07] [Scopus]
  • Worthley, D., Mullighan, C.G., Dean, M.M., Gordon, D.L., Phillips, P., Heatley, S., et al. (2007). Mannose-binding lectin deficiency does not increase the prevalence of Helicobacter pylori seropositivity. European Journal of Gastroenterology and Hepatology, 19(2) pp. 147-152.
    [10.1097/MEG.0b013e3280106729] [Scopus]
  • Worthley, D., Bardy, P.G., Gordon, D.L. and Mullighan, C.G. (2006). Mannose-binding lectin and maladies of the bowel and liver. World Journal of Gastroenterology, 12(40) pp. 6420-6428.
    [Scopus]
  • Unicomb, L.E., Ferguson, J., Stafford, R.J., Ashbolt, R., Kirk, M., Becker, N.G., et al. (2006). Low-level fluoroquinolone resistance among campylobacter jejuni isolates in Australia. Clinical Infectious Diseases, 42(10) pp. 1368-1374.
    [10.1086/503426] [Scopus]
  • Ormsby, R.J., Jokiranta, T.S., Duthy, T.G., Griggs, K.M., Sadlon, T., Giannakis, E., et al. (2006). Localization of the third heparin-binding site in the human complement regulator factor H. Molecular Immunology, 43(10) pp. 1624-1632.
    [10.1016/j.molimm.2005.09.012] [Scopus]
  • Hovis, K.M., Jones, J.P., Sadlon, T., Raval, G., Gordon, D.L. and Marconi, R.T. (2006). Molecular analyses of the interaction of Borrelia hermsii FhbA with the complement regulatory proteins factor H and factor H-like protein 1. Infection and Immunity, 74(4) pp. 2007-2014.
    [10.1128/IAI.74.4.2007-2014.2006] [Scopus]
  • Ju, O., Woolley, M. and Gordon, D.L. (2006). Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit. European Journal of Clinical Microbiology and Infectious Diseases, 25(1) pp. 61-62.
    [10.1007/s10096-005-0063-1] [Scopus]
  • O'Reilly, L.C., Inglis, T.J.J., Unicomb, L., Adamson, P., Cheung, K., Dalton, C., et al. (2006). Australian multicentre comparison of subtyping methods for the investigation of Campylobacter infection. Epidemiology and Infection, 134(4) pp. 768-779.
    [10.1017/S0950268805005777] [Scopus]
  • McDowell, J.V., Lankford, J., Stamm, L., Sadlon, T., Gordon, D.L. and Marconi, R.T. (2005). Demonstration of factor H-like protein 1 binding to Treponema denticola, a pathogen associated with peridontal disease in humans. Infection and Immunity, 73(11) pp. 7126-7132.
    [10.1128/IAI.73.11.7126-7132.2005] [Scopus]
  • Jokiranta, T.S., Cheng, Z.Z., Seeberger, H., Jozsi, M., Heinen, S., Noris, M., et al. (2005). Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. American Journal of Pathology, 167(4) pp. 1173-1181.
    [Scopus]
  • Giacomin, P.R., Wang, H., Gordon, D.L., Botto, M. and Dent, L.A. (2005). Loss of complement activation and leukocyte adherence as Nippostrongylus brasiliensis develops within the murine host. Infection and Immunity, 73(11) pp. 7442-7449.
    [10.1128/IAI.73.11.7442-7449.2005] [Scopus]
  • Fowler, V., Miro, J., Hoen, B., Cabell, C., Abrutyn, E., Rubinstein, E., et al. (2005). Staphylococcus aureus Endocarditis: A Consequence of Medical Progress. JAMA-Journal of The American Medical Association, 293(24) pp. 3012-3021.
    [10.1001/jama.293.24.3012] [Scopus] [Web Link]
  • Ellis-Grosse, E., Babinchak, T., Dartois, N., Rose, G., Loh, E. and Gordon, D. (2005). The Efficacy and Safety of Tigecycline in the Treatment of Skin and Skin-Structure Infections: Results of 2 Double-Blind Phase 3 Comparison Studies with Vancomycin-Aztreonam. Clinical Infectious Diseases, 41(Suppl 5) pp. 341-353.
    [10.1086/431675] [Scopus]
  • McRae, J.L., Duthy, T.G., Griggs, K.M., Ormsby, R.J., Cowan, P.J., Cromer, B.A., et al. (2005). Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with Lipoprotein. Journal of Immunology, 174(10) pp. 6250-6256.
    [Scopus]
  • Breedt, J., Teras, J., Gardovskis, J., Maritz, F., Vaasna, T., Ross, D., et al. (2005). Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam. Antimicrobial Agents and Chemotherapy, 49(11) pp. 4658-4666.
    [10.1128/AAC.49.11.4658-4666.2005] [Scopus]
  • Einsiedel, L., Gordon, D.L. and Dyer, J.R. (2004). Paradoxical inflammatory reaction during treatment of cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman. Clinical Infectious Diseases, 39(8) pp. e78-e82.
    [10.1086/424746]
  • Giacomin, P.R., Wang, H., Gordon, D.L. and Dent, L.A. (2004). Quantitation of complement and leukocyte binding to a parasitic helminth species. Journal of Immunological Methods, 289(1-2) pp. 201-210.
    [10.1016/j.jim.2004.04.024] [Scopus]
  • Friese, M.A., Manuelian, T., Junnikkala, S., Hellwage, J., Meri, S., Peter, H.H., et al. (2003). Release of endogenous anti-inflammatory complement regulators FHL-1 and factor H protects synovial fibroblasts during rhuematoid arthritis. Clinical and Experimental Immunology, 132(3) pp. 485-495.
    [10.1046/j.1365-2249.2003.02173.x] [Scopus]
  • Glannakis, E., Jokiranta, T.S., Male, D.A., Ranganathan, S., Ormsby, R.J., Fischetti, V.A., et al. (2003). A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. European Journal of Immunology, 33(4) pp. 962-969.
    [10.1002/eji.200323541] [Scopus]
  • Gordon, D.L. and Lee, S.A. (2003). Severe acute respiratory syndrome (SARS) Australian Journal of Medical Science, 24(2) pp. 79-83.
    [Scopus] [Web Link] [Web Link]
  • Hui, C.H., Au, V.W.K., Rowland, K., Slavotinek, J.P. and Gordon, D.L. (2003). Pulmonary nocardiosis re-visited:experiencce of 35 patients at diagnosis. Respiratory Medicine, 97(6) pp. 709-717.
    [10.1053/rmed.2003.1505] [Scopus]
  • Duthy, T.G., Ormsby, R.J., Giannakis, E., Ogunniyi, A.D., Stroeher, U.H., Paton, J.C., et al. (2002). The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15. Infection and Immunity, 70(10) pp. 5604-5611.
    [10.1128/IAI.70.10.5604-5611.2002] [Scopus]
  • Giannakis, E., Jokiranta, T.S., Ormsby, R.J., Duthy, T.G., Male, D.A., Christiansen, D., et al. (2002). Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46) Journal of Immunology, 168(9) pp. 4585-4592.
    [Scopus]
  • Giannakis, E., Male, D.A., Ormsby, R.J., Mold, C., Jokiranta, T.S., Ranganathan, S., et al. (2001). Multiple ligand binding sites on domain seven of human complement factor H. International Immunopharmacology, 1 pp. 443-443.
    [Scopus]
  • Jokiranta, T.S., Westin, J., Nilsson, U.R., Nilsson, B., Hellwage, J., Lofas, S., et al. (2001). Complement C3b interactions studied with surface plasmon resonance technique. International Immunopharmacology, 1 pp. 495-506.
    [Scopus]
  • Male, D.A., Ormsby, R., Ranganathan, S., Giannakis, E. and Gordon, D. (2000). Complement factor H: sequence analysis of 221kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes. Molecular Immunology, 37(1-2) pp. 41-52.
    [10.1016/S0161-5890(00)00024-9] [Scopus]
  • Ranganathan, S., Male, D.A., Ormsby, R.J., Giannakis, E. and Gordon, D.L. (2000). Pinpointing the putative heparin/sialic acid-binding residues in the 'sushi' domain 7 of factor H: a molecular modeling study. Pacific Symposium on Biocomputing, pp. 152-164.
    [Scopus] [Web Link] [Web Link]
  • Blackmore, T.K., Fischetti, V.A., Sadlon, T., Ward, H.M. and Gordon, D.L. (1998). M Protein of the Group A Streptococcus binds to the Seventh Short Consensus Repeat of Human Complement Factor H. Infection and Immunity, 66(4) pp. 1427-1431.
    [Scopus] [Web Link]
  • Blackmore, T.K., Hellwage, J., Sadlon, T., Higgs, N., Zipfel, P.F., Ward, H.M., et al. (1998). Identification of the Second Heparin-Binding Identification of the Second Heparin-Binding. Journal of Immunology, 160(7) pp. 3342-3348.
    [Scopus]
  • Ward, H., Higgs, N., Blackmore, T., Sadlon, T. and Gordon, D. (1997). Cloning and analysis of the human complement factor H gene promoter. Immunology and Cell Biology, 75(5) pp. 508-510.
    [10.1038/icb.1997.79]
  • Heath, C., Blackmore, T. and Gordon, D. (1996). Emerging resistance in Enterococcus spp. Medical Journal of Australia, 164(2) pp. 116-120.
    [Scopus]
  • Egan, A. and Gordon, D. (1996). Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes. Infection and Immunity, 64(12) pp. 4952-4959.
    [Scopus] [Web Link]
  • Blackmore, T.K., Sadlon, T., Ward, H.M., Lublin, D.M. and Gordon, D.L. (1996). Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. Journal of Immunology, 157 pp. 5422-5427.
    [Scopus]
  • LeMire, M., Wing, L. and Gordon, D. (1996). An audit of third generation cephalosporin prescribing in a tertiary care hospital. Australian and New Zealand Journal of Medicine, 26(3) pp. 386-390.
    [Scopus] [Web Link]
  • Blackmore, T., Reznikov, M. and Gordon, D. (1995). Clinical utility of the polymerase chain reaction to diagnose Mycoplasma pneumoniae infection. Pathology, 27(2) pp. 177-181.
    [Scopus] [Web Link]
  • Gordon, D., Kaufman, R., Blackmore, T., Kwong, J. and Lublin, D.M. (1995). Identification of complement regulatory domains in human factor H. Journal of Immunology, 155(1) pp. 348-356.
    [Scopus] [Web Link] [Web Link]
  • Hallsworth, P., Hefford, C., Waddell, R. and Gordon, D. (1995). Comparison of antigen detection, polymerase chain reaction and culture for detection of Chlamydia trachomatis in genital infection. Pathology, 27(2) pp. 168-171.
    [Scopus] [Web Link]
  • Parker, S., Sadlon, T. and Gordon, D. (1995). Enhancement of NK Cell-Mediated Antibody-Dependent Lysis of Recombinant gp120-Coated CD4 Cells by Complement. Journal of Infectious Diseases, 171(1) pp. 186-189.
    [Scopus] [Web Link] [Web Link]
  • Reznikov, M., Blackmore, T., Finlay-Jones, J. and Gordon, D. (1995). Comparison of nasopharyngeal aspirates and throat swab specimens in a polymerase chain reaction-based test for Mycoplasma pneumoniae. European Journal of Clinical Microbiology and Infectious Diseases, 14(1) pp. 58-61.
    [Scopus] [Web Link]
  • Tyring, S., Barbarash, R., Nahlik, J., Cunningham, A., Marley, J., Heng, M., et al. (1995). Famciclovir for the treatment of acute herpes zoster: effects on acute disease and posttherapeutic neuralgia. Annals of Internal Medicine, 123(2) pp. 89-96.
    [10.7326/0003-4819-123-2-199507150-00002]
  • Collignon, P. and Gordon, D. (1994). Intravascular catheter associated sepsis: a common problem. Medical Journal of Australia, 161(6) pp. 374-378.
    [Scopus] [Web Link]
  • Sadlon, T., Parker, S. and Gordon, D. (1994). Regulation of C3 deposition on gp120 coated CD4 positive cells by decay accelerating factor and factor H. Immunology and Cell Biology, 72(6) pp. 461-470.
    [10.1038/icb.1994.70]
  • Gordon, D., Papazaharoudakis, H., Sadlon, T., Arellano, A. and Okada, N. (1994). Upregulation of human neutrophil CD59, a regulator of the membrane attack complex of complement, following cell activation. Immunology and Cell Biology, 72(3) pp. 222-229.
    [10.1038/icb.1994.33]
  • Avery, V. and Gordon, D. (1993). Characterisation of factor H binding to human polymorphonuclear leukocytes. Journal of Immunology, 151(10) pp. 5545-5553.
    [Scopus] [Web Link]
  • Avery, V., Adrian, D. and Gordon, D. (1993). Detection of mosaic protein mRNA in human astrocytes. Immunology and Cell Biology, 71 pp. 215-219.
    [10.1038/icb.1993.24] [Web Link] [Web Link]
  • Hohmann, A., Booth, K., Peters, V., Gordon, D. and Comacchio, R. (1993). A common epitope on HIV p24 and human platelets. Lancet, 342(8882) pp. 1274-1275.
    [Scopus] [Web Link]
  • Gordon, D., Sadlon, T., Hefford, C. and Adrian, D. (1993). Expression of CD59, a regulator of the membrane attack complex of complement, on human astrocytes. Molecular Brain Research, 18(4) pp. 335-338.
    [Scopus]
  • Smart, D., Baggoley, C., Head, J., Noble, D., Wetherall, B. and Gordon, D. (1993). Effect of needle changing and intravenous cannula collection on blood culture contamination rates. Annals of Emergency Medicine, 22(7) pp. 1164-1168.
    [10.1016/S0196-0644(05)80983-7] [Scopus]
  • Gordon, D., Avery, V., Adrian, D. and Sadlon, T. (1992). Detection of complement protein mRNA in human astrocytes by the polymerase chain reaction. Journal of Neuroscience Methods, 45(3) pp. 191-197.
    [Scopus] [Web Link]
  • Gordon, D., Sadlon, T., Wesselingh, S., Russell, S., Johnstone, R. and Purcell, D. (1992). Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation. Journal of Neuroimmunology, 36(2-3) pp. 199-208.
    [Scopus]
  • Avery, V. and Gordon, D. (1991). Antibacterial properties of breast milk: requirements for surface phagocytosis and chemiluminescence. European Journal of Clinical Microbiology and Infectious Diseases, 10(12) pp. 1034-1039.
    [Scopus]
  • Blue, A. and Gordon, D. (1991). Is primary sensitivities testing on urine isolates valid? Pathology, 23(2) pp. 149-152.
    [10.3109/00313029109060815] [Web Link]
  • Butt, H., Gordon, D., Lee-Archer, T., Moritz, A. and Merrell, W. (1991). Relationship between clinical and milk isolates of Yersinia enterocolitica. Pathology, 23(2) pp. 153-157.
    [Scopus]
  • Gordon, D., Rice, J. and Avery, V. (1990). Surface phagocytosis and host defence in the peritoneal cavity during continuous ambulatory peritoneal dialysis. European Journal of Clinical Microbiology and Infectious Diseases, 9(3) pp. 191-197.
    [Scopus] [Web Link]
  • Gordon, D., Avery, V., Rice, J. and McDonald, P. (1989). Surface phagocytosis of Staphylococcus epidermidis and Escherichia coli by human neutrophils: serum requirements for opsonization and chemiluminescence. Fems Immunology and Medical Microbiology, 1(8-9) pp. 417-423.
    [10.1111/j.1574-6968.1989.tb02433.x]
  • Gordon, D., Rice, J. and McDonald, P. (1989). Regulation of human neutrophil type 3 complement receptor (iC3b receptor) expression during phagocytosis of Staphylococcus aureus and Escherichia coli. Immunology, 67(4) pp. 460-465.
    [Scopus]
  • Gordon, D. (1988). Serum bactericidal activity against Haemophilus influenzae. Pathology, 20(2) pp. 124-129.
    [10.3109/00313028809066622] [Web Link]
  • Gordon, D. and Rice, J. (1988). Opsonin-dependent and independent surface phagocytosis of S. aureus proceeds independently of complement and complement receptors. Immunology, 64(4) pp. 709-714.
    [Scopus]
  • Gordon, D., Rice, J., Finlay-Jones, J., McDonald, P. and Hostetter, M. (1988). Analysis of C3 Deposition and Degradation on Bacterial Surfaces After Opsonization. Journal of Infectious Diseases, 157(4) pp. 697-704.
    [10.1093/infdis/157.4.697]
  • Gordon, D., Johnson, G. and Hostetter, M. (1987). Characteristics of iC3b binding to human polymorphonuclear leucocytes. Immunology, 60(4) pp. 553-558.
    [Scopus] [Web Link]
  • Gordon, D. and Hostetter, M. (1986). Complement and Host Defence Against Microorganisms. Pathology, 18(4) pp. 365-375.
    [Scopus] [Web Link]
  • Gordon, D., Johnson, G. and Hostetter, M. (1986). Ligand-receptor interactions in the phagocytosis of virulent Streptococcus pneumoniae by polymorphonuclear leukocytes. Journal of Infectious Diseases, 154(4) pp. 619-626.
    [10.1093/infdis/154.4.619]
  • Gordon, D., Krueger, R., Quie, P. and Hostetter, M. (1985). Amidation of C3 at the thiolester site: stimulation of chemiluminescence and phagocytosis by a new inflammatory mediator. Journal of Immunology, 134(5) pp. 3339-3345.
    [Scopus]
  • Young, G., Ward, P., Bayley, N., Gordon, D., Higgins, G., Trapani, J., et al. (1985). Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. Gastroenterology, 89(5) pp. 1038-1045.
    [Scopus] [Web Link]
  • Gordon, D., Bune, A., Grime, B., McDonald, P., Marshall, V., Marsh, J., et al. (1983). Diagnostic criteria and natural history of catheter-associated urinary infections after prostatectomy. Lancet, 322(8362) pp. 1269-1271.
    [Scopus] [Web Link]
  • Phillips, C., McKinnon, R.A., Woodman, R.J. and Gordon, D.L. (2017). Junior doctors’ preparedness to prescribe, monitor and treat patients with the antibiotic vancomycin in an Australian teaching hospital. Journal of Educational Evaluation for Health Professionals, 14(13)
    [10.3352/jeehp.2017.14.13]
  • Phillips, C., McKinnon, R.A., Woodman, R.J. and Gordon, D.L. (2017). Sustained improvement in vancomycin dosing and monitoring post implementation of guidelines: results of a three-year follow-up after a multifaceted intervention. JOURNAL OF INFECTION AND CHEMOTHERAPY,
  • Adamson, P., Al Kindi, M., Wang, J.J., Colella, A., Chataway, T.K., Petrovsky, N., et al. (2017). Proteomic analysis of influenza haemagglutinin-specific antibodies following vaccination reveals convergent immunoglobulin variable region signatures. Vaccine, 35(42) pp. 5576-5580.
    [10.1016/j.vaccine.2017.08.053] [Scopus]
  • Honda-Okubo, Y., Rajapaksha, H., Sajkov, D., Gordon, D.L., Cox, M.M. and Petrovsky, N. (2017). Panblok-H1+Advax H1N1/2009pdm vaccine: insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine. Human Vaccines & Immunotherapeutics,
    [10.1080/21645515.2017.1279765]
  • Phillips, C., Wells, N.A., Martinello, M., Smith, S., Woodman, R.J. and Gordon, D.L. (2016). Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range. Infection and Drug Resistance, 9 pp. 87-92.
    [10.2147/IDR.S107961] [Scopus] [Web Link]
  • Hewagama, S., Spelman, T., Woolley, M., McLeod, J., Gordon, D.L. and Einsiedel, L.J. (2016). The Epidemiology of Staphylococcus aureus and Panton-Valentine Leucocidin (pvl) in Central Australia, 2006-2010. BMC Infectious Diseases, 16 pp. 382-387.
    [10.1186/s12879-016-1698-5]
  • Gordon, D.L., Sajkov, D., Honda-Okubo, Y., Wilks, S.H., Aban, M., Barr, I.G., et al. (2016). Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with AdvaxTM Delta Inulin Adjuvant. Vaccine, 34(33) pp. 3780-3786.
    [10.1016/j.vaccine.2016.05.071]
  • Tucker, E. and Gordon, D. (2012). Miscellaneous antibacterial drugs. In Side Effects of Drugs Annual 34. U.K.: Elsevier, pp. 399-425.
    [10.1016/B978-0-444-59499-0.00026-X]
  • Gordon, D.L. (2010). Amoxicillin-Clavulanic Acid (Co-Amoxiclav) In M. Lindsay Grayson, ed. Kucers' The Use of Antibiotics. 6th ed. United Kingdom: Hodder, pp. 187-203.
  • Gordon, D.L. (2010). Meningitis and Encephalitis. In Margaret Schuller, Theo P. Sloots, Gregory S. James, Catriona L. Halliday, Ivan W.J. Carter, ed. PCR for Clinical Microbiology. Australia: Springer, pp. 63-66.
    [10.1007/978-90-481-9039-3_4] [Scopus]

Expertise for media contact

Subject Titles

  • AIDS
  • Antibiotics
  • Immunology
  • Infection/Infectious Diseases

Interests

  • Control of Infectious Diseases
  • Hepatitis C
  • Diagnosis of Infections
  • Complement System
  • Immunology
  • Treatment of Infectious Diseases
  • Aids
  • Antibiotics

Contact

Add to address book
Phone: +61 8 82045293
Email:
Location: Flinders Medical Centre (5D:304)
Postal address: GPO Box 2100, Adelaide 5001, South Australia
MACO login

inspiring achievement